English Journal
- [Chemoradiotherapy in early stage Hodgkin's lymphoma].
- Farha G, Nasr E, Ghosn M, Nasr DN, Nasr F, Kattan J, Azoury F, Aftimos P, Chahine G.SourceServices de Radiothérapie oncologique, Hôtel-Dieu de France, Beyrouth, Liban.
- Le Journal médical libanais. The Lebanese medical journal.J Med Liban.2011 Jul-Sep;59(3):122-5.
- OBJECTIVE: To evaluate the response to and toxicities of chemo-radiotherapy (CT-RT) in patients with early stage Hodgkin lymphoma treated in our institution.MATERIALS AND METHODS: Retrospective study of 42 patients with early stage Hodgkin lymphoma treated between 2002 and 2007.RESULTS: The age of p
- PMID 22259898
- A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck.
- Buiret G, Combe C, Favrel V, Pommier P, Martin L, Ecochard R, Fayette J, Tartas S, Ramade A, Céruse P.SourceService d'ORL, Centre Hospitalier Universitaire Lyon Sud, Pierre-Bénite, France. guillaume.buiret@laposte.net
- International journal of radiation oncology, biology, physics.Int J Radiat Oncol Biol Phys.2010 Jun 1;77(2):430-7. Epub 2009 Sep 21.
- PURPOSE: To investigate, in a multicenter study, the tolerance of induction chemotherapy (ICT) and external radiotherapy (ERT) with concomitant cetuximab in the treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).PATIENTS AND METHODS: Clinical data from 46 patients with S
- PMID 19775831
Japanese Journal
- 舌癌に対する超選択的動注併用照射療法の効果
- 遠藤 壮平,鈴木 伸,辻 賢三,丹羽 秀夫,野口 雄五,吉田 憲司,木田 亮紀,田中 良明,氷見 和久,竹本 明子
- 日本耳鼻咽喉科学会会報 108(6), 689-693, 2005
- 1996年から2002年の間に舌癌20例に対して施行された超選択的動注併用照射療法について検討した. stageはstage IIが10例, stage IIIが4例, stage IV Aが6例であった. 動注PF療法併用照射療法 (n=14) での局所制御率はT2で50%, T3で67%, T4で0%であった. 動注TPF変法併用照射療法 (n=6) では全例局所が制御された. 全体での5年死 …
- NAID 130000992090
- 上顎癌の術前照射療法における臨床的および病理組織学的研究
- 森田 守
- 日本耳鼻咽喉科学会会報 68(3), 333-350, 1965
- … doses of the irradiation were measured with the miniature glass rods and ranged from 2000 rads to 4000 rads.Cases were maxillectomized within three weeks after irradiation, and the insufficiency of the doses of the preoperative irradiation was supplied post-operatively.Any outstanding change of the hematological and biochemical finding of the serum after the irradiation was not observed except for slight leucopenia.Even severe radiomucositis subsided usually within two weeks after irradiation, and no harmful effect to surgical procedure was …
- NAID 130000803056
Related Links
- The effect of systemic enzyme therapy (Phlogenzym) in the treatment of radiomucositis in patients with laryngeal cancer. Pluzhnikov M. S., Ryabova M.A., Karpiscenko S.A.. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae 1999, Vol.
Related Pictures
★リンクテーブル★
| リンク元 | 「放射線粘膜炎」 |